Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth
出版年份 2018 全文链接
标题
Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth
作者
关键词
-
出版物
Scientific Reports
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-01-26
DOI
10.1038/s41598-018-20179-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Essential Medicinal Chemistry of Curcumin
- (2017) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Deceptive curcumin offers cautionary tale for chemists
- (2017) Monya Baker NATURE
- Don't discount all curcumin trial data
- (2017) Michal Heger NATURE
- Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth
- (2016) Shira L Cramer et al. NATURE MEDICINE
- ROS homeostasis and metabolism: a dangerous liason in cancer cells
- (2016) E Panieri et al. Cell Death & Disease
- Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
- (2015) Isaac S. Harris et al. CANCER CELL
- Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase – Carbonyl reductase 1
- (2015) Jan Hintzpeter et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Biological and therapeutic activities, and anticancer properties of curcumin
- (2015) DONATELLA PERRONE et al. Experimental and Therapeutic Medicine
- Cellular mechanisms and physiological consequences of redox-dependent signalling
- (2014) Kira M. Holmström et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis
- (2012) Seung Joon Lee et al. BMC CANCER
- Very long-term follow-up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy
- (2012) Hagop Kantarjian et al. CANCER
- Physiological Roles of Mitochondrial Reactive Oxygen Species
- (2012) Laura A. Sena et al. MOLECULAR CELL
- Early cytogenetic and molecular response during first-line treatment of chronic myeloid leukemia in chronic phase
- (2011) Alfonso Quintás-Cardama et al. CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
- (2010) Mathilde Bayet-Robert et al. CANCER BIOLOGY & THERAPY
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibition of human glutathioneS-transferases by curcumin and analogues
- (2009) R. Appiah-Opong et al. XENOBIOTICA
- Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells
- (2008) A. Kunwar et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Molecular biology of bcr-abl1-positive chronic myeloid leukemia
- (2008) A. Quintas-Cardama et al. BLOOD
- ROS and p53: A versatile partnership
- (2008) Bin Liu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Curcumin Inhibits Glyoxalase 1—A Possible Link to Its Anti-Inflammatory and Anti-Tumor Activity
- (2008) Thore Santel et al. PLoS One
- Anti cancer effects of curcumin: cycle of life and death
- (2008) Gaurisankar Sa et al. Cell Division
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started